SEC Form 4 · accession 0001225208-17-012888
Cigna Holding Co · CI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane E Henney M.D.
Director
Period of report
Jul 24, 2017
Accepted (ET)
Jul 25, 2017 · 6:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000701221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.25 Par ValueF2 | Jul 24, 2017 | S | 600 | $174.14 | D | 14,877 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2016.
- F2The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 26 and 87 of Cigna's proxy statement filed with the SEC on March 18, 2017.